Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

T CELL RECEPTOR PEPTIDE MAY HELP TREAT MS

Jan. 28, 1991

AMYLIN TAKES NEW ROAD TO DIABETES TREATMENT

Jan. 25, 1991

MILITARY SPOKESMEN DENY XOMA DEAL

Jan. 25, 1991

JOURNAL SCAN

Jan. 25, 1991

EARNINGS REPORTS

Jan. 25, 1991

NEWS BRIEFS

Jan. 25, 1991

ESCAGENETICS BUYS OUT VENTURE PARTNER

Jan. 25, 1991

012591PATENTS1

Jan. 25, 1991

PATENTS, Part 2 of 2 U.S. Class: 435--191

Jan. 25, 1991

BIOSURFACE MAY SUPPLY ARMY WITH SKIN GRAFTS

Jan. 24, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...